|
English
|
正體中文
|
简体中文
|
2827024
|
|
???header.visitor??? :
32012220
???header.onlineuser??? :
922
???header.sponsordeclaration???
|
|
|
|
???tair.name??? >
???browser.page.title.author???
|
"streinu cercel a"???jsp.browse.items-by-author.description???
Showing items 1-7 of 7 (1 Page(s) Totally)
1
View [10|25|50] records per page
| 臺大學術典藏 |
2021-09-04T06:11:25Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti M.; Flisiak R.; JIA-HORNG KAO; Chuang W.-L.; Streinu-Cercel A.; Tabak F.; Calistru P.; Goeser T.; Rasenack J.; Horban A.; Davis G.L.; Alberti A.; Mazzella G.; Pol S.; Orsenigo R.; Brass C. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
State of the antiretroviral therapy in human immunodeficiency virus drug resistance: Surveillance and regional gaps
|
Marcelin A.-G.; Kaiser R.; Boucher C.A.; Bobkova M.R.; CHIEN-CHING HUNG; Streinu-Cercel A.; van Wyk J.; Dorr P.; Vandamme A.-M. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
State of the Art in HIV Drug Resistance: Science and Technology Knowledge Gap
|
Boucher C.A.; Bobkova M.R.; Geretti A.M.; CHIEN-CHING HUNG; Kaiser R.; Marcelin A.-G.; Streinu-Cercel A.; van Wyk J.; Dorr P.; Vandamme A.-M. |
| 臺大學術典藏 |
2020-09-30T03:22:26Z |
State of the antiretroviral therapy in human immunodeficiency virus drug resistance: Science and technology knowledge gap
|
Streinu-Cercel A.; van Wyk J.; Dorr P.; Vandamme A.-M.; Marcelin A.-G.; Kaiser R.; Boucher C.A.; Bobkova M.R.; Geretti A.M.; CHIEN-CHING HUNG |
| 臺大學術典藏 |
2020-09-30T03:22:25Z |
State of the Art in HIV Drug Resistance: Surveillance and Regional Gaps
|
Boucher C.A.;Bobkova M.R.;Chien-Ching Hung;Kaiser R.;Marcelin A.-G.;Streinu-Cercel A.;Van Wyk J.;Dorr P.;Vandamme A.-M.; Boucher C.A.; Bobkova M.R.; CHIEN-CHING HUNG; Kaiser R.; Marcelin A.-G.; Streinu-Cercel A.; van Wyk J.; Dorr P.; Vandamme A.-M. |
| 臺大學術典藏 |
2018-09-10T15:24:48Z |
Alisporivir with peginterferon/ribavirin in patients with chronic hepatitis C genotype 1 infection who failed to respond to or relapsed after prior interferon-based therapy: FUNDAMENTAL, a Phase II trial
|
Buti, M.;Flisiak, R.;Kao, J.-H.;Chuang, W.-L.;Streinu-Cercel, A.;Tabak, F.;Calistru, P.;Goeser, T.;Rasenack, J.;Horban, A.;Davis, G.L.;Alberti, A.;Mazzella, G.;Pol, S.;Orsenigo, R.;Brass, C.; JIA-HORNG KAO |
| 國立臺灣大學 |
2013 |
ALISPORIVIR (ALV) PLUS PEGINTERFERON/RIBAVIRIN (PR) ACHIEVES HIGH SVR12 RATES AMONG NULL RESPONDERS, IL28BCT/TT AND CIRRHOTIC HCVG1 PATIENTS (FUNDAMENTAL STUDY INTERIM ANALYSIS)
|
Buti, M.; Flisiak, R.; Rasenack, J.; Davis, G.; Alberti, A.; Goeser, T.; Stanciu, C.; Chuang, W. -L.; Tabak, F.; Kao, J. -H.; Streinu-Cercel, A.; Hofstetter, G.; Wang, J.; Avila, C.; Orsenigo, R.; 高嘉宏 |
Showing items 1-7 of 7 (1 Page(s) Totally)
1
View [10|25|50] records per page
|
